# Why the rules are in flux

Lesson 1 of [Compare peptide providers as the rules change](https://peptideclinic.fyi/academy/compare-peptide-providers-as-rules-change.md), 12 minutes.

Rules on which peptides a pharmacy may compound are changing. This lesson shows how to read news about them. It does not tell you what is allowed. The FDA page does.

## Two tracks

US law splits compounding into 503A pharmacies and 503B outsourcing facilities. A 503A pharmacy is state-licensed and compounds for individual patients. A 503B facility registers with the FDA. The site's guide says different bulk-substance rules apply to each.

## Bulks lists and categories

The site's guide says the FDA is still developing the bulks lists for both sections. It says the FDA groups nominated substances. Category 1 is under evaluation. Category 2 raises significant safety risks. Category 3 was nominated without adequate support.

## Why this course gives no status

The site's guide, checked on 2026-10-20, describes a February 2026 HHS announcement about some peptides and the FDA categories. It says sources disagree on the final status and on what the announcement changes in practice. News in this area keeps moving. So this course does not repeat a status or a count of peptides. Read the FDA page for the current status, and check its date.

## How to read a notice like this

- Find the date. A status can go stale.
- Find the primary source. Read the FDA bulk-substances page.
- Treat one article or one marketing page as a claim, not as the status.
- Do not rely on a clinic to tell you the current status. Ask it in writing where it reads the status. Then check the FDA page yourself.

## What you can and cannot settle

You can ask a provider whether its product is offered within the current rules. You can read the FDA page. You cannot settle a legal question yourself. Ask a qualified professional about your own case.

## Sources

- PeptideClinic guide, FDA rules for compounded peptides, in plain words, updated 2026-10-20
- PeptideClinic guide, Peptide clinic rules in the United States, updated 2026-10-20
- FDA, Bulk drug substances used in compounding: https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-used-compounding

This course is general information, not medical, legal or financial advice.

Also on the [web page](https://peptideclinic.fyi/academy/compare-peptide-providers-as-rules-change/why-the-rules-are-in-flux).

> In an emergency call 911.
